Skip to content

Assessing the effect of tDCS on opioid addicts and their brain function

Assessing Executive Function and Drug Craving Modulatory Effects of Transcranial Direct Current Stimulation (tDCS) among Opioid Dependents

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200927048850N1
Enrollment
72
Registered
2020-10-10
Start date
2020-10-22
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug use disorder. Opioid abuse with other opioid-induced disorder

Interventions

Intervention 1: Intervention group: Transcranial Direct Current Stimulation (tDCS) is performed 2 times a day for 5 consecutive days. Stimulation is performed twice in the intervention group for 13 mi

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Subjects have to be male Subject who is right-handed Subject whose age is between 18 to 55 years At least the fifth elementary education Have opioid dependence criteria based on DSM-5 criteria Have no other psychiatric or neurological illness The main substance consumption have to be opium Do not consume other substances during the project Subject consents to participation in the study and provides a signed informed consent form

Exclusion criteria

Exclusion criteria: Contraindications to tDCS include the presence of any type of cerebral injury in the brain and metal plates on the head, chronic skin problems, severe reactions to tDCS in previous treatments, history of seizures

Design outcomes

Primary

MeasureTime frame
Rate of changes in baseline substance craving and cue-induced craving. Timepoint: Before the intervention and after the intervention (fifth day) and 2 months later. Method of measurement: Visual Analog Scale, Desire for Drug Questionnaire, Obsessive-Compulsive Drug Use Scale.;Serum level changes of Brain-Derived Neurotrophic Factor. Timepoint: Before the intervention and after the intervention (fifth day). Method of measurement: Enzyme-Linked Immunosorbent Assay(ELISA).;Evaluation of changes in short-term memory and working memory. Timepoint: Before the intervention and after the intervention (fifth day) and 2 months later. Method of measurement: Forward & Backward Digit span Test.;Evaluation of changes in response inhibition and impulsivity. Timepoint: Before the intervention and after the intervention (fifth day) and 2 months later. Method of measurement: Go-No Go Test.;Evaluation of changes in decision making and risk-taking. Timepoint: Before the intervention and after the intervention (fifth day) and 2 months later. Method of measurement: Balloon Analog Risk Task (BART).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoghieh Bahareh Borzooee

Shahroud University of Medical Sciences

b.borzooee@shmu.ac.ir+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026